Prophylactic Treatment of Migraine With an Angiotnesin II Receptor Blocker
JAMA 289:65-69, Tronvik,E.,et al, 2003
An Organic Cause of Neuropsychiatric Illness in Adolescence
Lancet 361:572, Taylor,S.E.,et al, 2003
Development of Generalized Disease at 2 Years in Patients with Ocular Myasthenia Gravis
Arch Neurol 60:243-248, Kupersmith,M.J.,et al, 2003
Hashimoto Encephalopathy
Arch Neurol 60:164-171, Chong,J.Y.,et al, 2003
Slowing Parkinson's Disease Progression
Neurol 60:381-389, Ahlskog,J.E., 2003
Initial Agonist Treatment of Parkinson Disease
Neurol 60:390-394, Albin,R.L. &Frey,K.A., 2003
Intranasal Sumatriptan in Cluster Headache
Neurol 60:630-633, van Vliet,J.A.,et al, 2003
[123I]b-CIT SPECT is a Useful Method for Monitoring Dopaminergic Degeneration in Early Stage Parkinson's Disease
JNNP 74:294-298,287, Winogrodzka,A.,et al, 2003
MR Imaging of Autopsy-Proved Paraneoplastic Limbic Encephalitis in Non-Hodgkin Lymphoma
AJNR 24:507-511, Thuerl,C.,et al, 2003
Amnesia, Cerebral Atrophy, and Autoimmunity
Lancet 361:1266, Schott,J.M., et al, 2003
Migraine--Current Understanding and Treatment
NEJM 346:257-270, Goadsby,P.J.,et al, 2002
Excessive Daytime Sleepiness and Sudden-Onset Sleep in Parkinson Disease
JAMA 287:455-463,509, Hobson,D.E.,et al, 2002
Cerebral Vasoconstriction and Stroke After Use of Serotonergic Drugs
Neurol 58:130-133, Singhal,A.B.,et al, 2002
Almotriptan (AXERT) and Frovatriptan (FROVA) for Migraine
The Medical Letter 44:19-20, , 2002
The Safety of Triptans in the Treatment of Patients with Migraine
Am J Med 112:135-140, Jamieson,D.G., 2002
Alopecia Induced by Dopamine Agonists
Neurol 58:829-830, Tabamo,R.E. &Di Rocco,A., 2002
Paraneoplastic Chorea Associated with CRMP-5 Neuronal Antibody and Lung Carcinoma
Ann Neurol 51:625-630, Vernino,S.,et al, 2002
Dopamine Transporter Brain Imaging to Assess the Effects of Pramipexole vs Levodopa on Parkinson Disease Progression
JAMA 287:1653-1661, Parkinson Study Group, 2002
SUNCT Syndrome in Two Patient with Prolactinomas and Bromocriptine-Induced Attacks
Neurol 58:1698-1699, Massiou,H.,et al, 2002
Reduced Incidence of AD with NSAID But Not H2 Receptor Antagonists
Neurol 59:880-886, Zandi,P.P.,et al, 2002
Delirium Resulting From Paraneoplastic Limbic Encephalitis Caused by Hodgkins Disease
Psychosomatics 43:498-501, Kung,S.,et al, 2002
What Matters is Not the Differences Between Triptans, but the Differences Between Patients
Arch Neurol 58:1481-1482, Saper,J.R., 2001
Triptans Are All Different
Arch Neurol 58:1479-1480,1482, Rapoport,A.M.&Tepper,S.J., 2001
A randomized,Double-blind,Placebo-Controlled Trial of Subcutaneously Injected Apomorphine for Parkinsonian Off-State Events
Arch Neurol 58:1385-1392, Dewey,R.B.,et al, 2001
Tourette's Syndrome
NEJM 345:1184-1192, Jankovic,J., 2001
Ten-year Follow-up of Three Different Initial Treatments in De-novo PD
Neurol 57:1687-1694, Lees,A.J.,et al, 2001
Human Herpesvirus 6 Limbic Encephalitis After Stem Cell Transplantation
Ann Neurol 50:612-619, Wainwright,M.S.,et al, 2001
Oral Triptans (serotonin 5-HT 1B/1D agnosists) in Acute Migraine Treatment: A Meta-analysis of 53 Trials
Lancet 358:1668-1675, Ferrari,M.D.,et al, 2001
Intracranial Hemorrhages Associated with Sumatriptan
Neurol 56:1243-1244, Combremont,P.C. & Marcus,E.M., 2001
Paraneoplastic Striatal Encephalitis
Neurol 57:2326, Oguma,T.,et al, 2001
Safety of Pramipexole in Patients with Restless Legs Syndrome
Neurol 55:1589-1590, Stiasny,K.,et al, 2000
Limbic Encephalitis Not Associated with Neoplasm as a Cause of Temporal Lobe Epilepsy
Neurol 55:1823-1828, Bien,C.G.,et al, 2000
Amnesic Syndrome with Bilateal Mesial Temporal Lobe Involvement in Hashimoto's Encephalopathy
Neurol 54:737-739, McCabe,D.J.H.,et al, 2000
Eletriptan in Acute Migraine:A Double-Blind,Placebo-Controlled Comparison to Sumatriptan
Neurol 54:156-163, Goadsby,P.J.,et al, 2000
Tourette's Syndrome Improvement with Pergolide in a Randomized, Double-Blind, Crossover Trial
Neurol 54:1310-1315, Gilbert,D.L.,et al, 2000
Triptans and Migraine
Lancet 355:860-861, Bateman,D.N., 2000
Reduced Prevalence of AD in Users of NSAIDs and H2 Receptor Antagonists
Neurol 54:2066-2071, Anthony,J.C.,et al, 2000
Dopamine Agonists: Their Role in the Treatment of Parkinson's Disease
JNNP 68;685-690, Brooks,D.J., 2000
Hypersexuality in Patients with Dementia: Possible Response to Cimetidine
Neurol 54:2024, Wiseman,S.V.,et al, 2000
Clinical Characteristics of Pramipexole-Induced Peripheral Edema
Arch Neurol 57:729-732, Tan,E.K.&Ondo,W., 2000
A Five-Year Study of the Incidence of Dyskinesia in Patients With Early Parkinson's Disease who were Treated with Ropinirole or Levodopa
NEJM 342:1484-1491, Rascol,O.,et al, 2000
Oral Zolmitriptan is Effective in the Acute Treatment of Cluster Headache
Neurol 54:1832-1839, Bahra,A.,et al, 2000
Life-Threatening Tinnitus
Lancet 356:308, Javaheri,S. et al, 2000
Atrial Fibrillation Associated with Sumatriptan
BMJ 321:275, Morgan,D.R. et al, 2000
Serotonin Sydrome
Medicine 79:201-209, Mason,P.J. et al, 2000
Autoantibodies to Ganglionic Acetylcholine Receptors in Autoimmune Autonomic Neuropathies
NEJM 343:847-855, Verning,S. et al, 2000
A Randomized, Double-Blind, Placebo-Controlled Study of Sumatriptan Nasal Spray in the Treatment of Acute Migraine in Adolescents
Pediatrics 106:989-997, Winner,P.,et al, 2000
Acute Orhtostatic Hypotension When Starting Dopamine Agonists in Parkinson's Disease
Arch Neurol 57:1461-1463, Kujawa,K.,et al, 2000
Pramipexole vs Levodopa as Initial Treatment for Parkinson Disease
JAMA 284:1931-1938,1971, Parkinson Study Group, 2000
Chorea Resulting From Paraneoplastic Striatal Encephalitis
JNNP 69:512-515, Tani,T.,et al, 2000